Concepedia

Publication | Open Access

Sofosbuvir and ribavirin in adolescents 12‐17 years old with hepatitis C virus genotype 2 or 3 infection

DOIFull Paper Access

104

Citations

20

References

2017

Year

Stefan Wirth, Philip Rosenthal, Regino P. González‐Peralta, Maureen M. Jonas, William F. Balistreri, Chuan‐Hao Lin, Winita Hardikar, Kathryn Kersey, Benedetta Massetto, Bittoo Kanwar,
Hepatology

Abstract

Sofosbuvir and ribavirin was safe and highly effective in adolescents with chronic hepatitis C virus genotype 2 or 3 infection. (Hepatology 2017;66:1102-1110).

References

YearCitations

Page 1